Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-15,233
Closed -$1.13M 402
2021
Q1
$1.13M Sell
15,233
-8,297
-35% -$630K 0.03% 219
2020
Q4
$1.71M Hold
23,530
0.05% 181
2020
Q3
$1.56M Buy
+23,530
New +$1.49M 0.05% 173
2020
Q1
$826K Buy
+23,530
New +$1.12M 0.03% 197

Other funds holding HOLX

Bradley Foster & Sargent's HOLX Position: Q2 2021 in Review

Bradley Foster & Sargent sold out of Hologic (HOLX) in Q2 2021, closing a stake of 15,233 shares — an estimated $1.13M sold.

Bradley Foster & Sargent first reported a position in HOLX in Q1 2020 and held it in 4 quarters. The position peaked at $1.71M in Q4 2020. 625 funds tracked by Wall St. Rank hold HOLX as of Q2 2021.

  • Bradley Foster & Sargent reported no remaining Hologic position as of Q2 2021 after selling out during the quarter.
  • Bradley Foster & Sargent sold 15,233 Hologic shares in Q2 2021, an estimated $1.13M.
  • Bradley Foster & Sargent first reported a position in Hologic in Q1 2020 and held it in 4 quarters.
  • Bradley Foster & Sargent's Hologic position peaked at $1.71M in Q4 2020.
  • 625 funds tracked by Wall St. Rank held Hologic as of Q2 2021.

Based on Bradley Foster & Sargent's 13F filing for Q2 2021, filed 19 Aug 2021.